20.06.2011 • Videos

Thomas Gründemann of Ferak Berlin on Custom Synthesis Trends

Ferak Berlin CEO Thomas Grünemann took a few minutes at this year's Chemspec Europe in Geneva to talk to CHEManager Europe Editor-in-Chief Brandi Schuster about custom synthesis and his company's "one product per campaign" strategy.

Company

Ferak Berlin GmbH

Lahnstr. 34
12055 Berlin
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Top-Feature

most read